Won Hyuk Chang | Rehabilitation | Best Researcher Award

Prof. Dr. Won Hyuk Chang | Rehabilitation | Best Researcher Award

Prof. Dr. Won Hyuk Chang, Samsung Medical Center, South Korea

Prof. Dr. Won Hyuk Chang is a distinguished expert in Physical and Rehabilitation Medicine at Samsung Medical Center and Professor at Sungkyunkwan University School of Medicine, Seoul πŸ‡°πŸ‡·. With over two decades of clinical, academic, and research excellence, he leads rehabilitation innovation, particularly for stroke and brain disorders. Dr. Chang’s pivotal work spans neurorehabilitation, robotic rehabilitation, non-invasive brain stimulation, and smart health technology. His international exposure includes a research fellowship at Harvard Medical School’s Beth Israel Deaconess Medical Center πŸ‡ΊπŸ‡Έ. As a section editor and board member for several prestigious journals, he contributes significantly to global stroke and neurorehabilitation literature. He also serves on various Korean and international scientific boards, reflecting his leadership in the field. Passionate about personalized treatment and patient-centered care, Prof. Chang actively directs multiple national research grants and has become a recognized figure in brain health innovation. πŸ§ πŸ¦ΎπŸ“š

Publication Profile

Orcid

πŸŽ“ Education

Prof. Dr. Won Hyuk Chang pursued his M.D. (2000) and M.S. (2005) from Yonsei University College of Medicine, followed by a Ph.D. in 2012 from Korea University College of Medicine πŸŽ“. His postgraduate clinical training began with an internship (2000–2001) and residency (2001–2005) in the Department of Rehabilitation Medicine at Severance Hospital, Yonsei University. This strong academic foundation provided him with clinical and research competencies essential for advanced rehabilitation medicine. His commitment to academic growth is further illustrated by his research fellowship at the Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center, Harvard Medical School (2014–2015). Through rigorous academic training in both Korea and the U.S., Dr. Chang has cultivated a multidisciplinary approach to neurorehabilitation and brain stimulation, leading to a prolific research and clinical career. πŸ“˜πŸ“–πŸ§ 

πŸ’Ό Experience

Dr. Chang’s career started as a Military Chief at Kangwha Hospital (2005–2008), later returning to Yonsei University as a Clinical Instructor (2008–2009). He joined Samsung Medical Center in 2009 and progressed from Clinical Instructor to Clinical Assistant Professor, then Assistant Professor (2011–2015), Associate Professor (2015–2021), and Professor (2021–present) at Sungkyunkwan University School of Medicine πŸ₯πŸ“ˆ. His international fellowship at Harvard Medical School in 2014-2015 boosted his research on brain stimulation. He is also involved in several professional societies, such as the Korean Society for Neurorehabilitation, Korean Neuromodulation Society, and Society for Neuroscience 🌐. Editorially, he serves as Section Editor for the Journal of Stroke and Editor for Geriatric Rehabilitation, among others. His clinical and academic leadership spans brain disorders, robotic and digital rehabilitation, and translational neuroscience πŸ§¬πŸ§‘β€βš•οΈ.

πŸ† Awards & Honors

Prof. Chang has been entrusted with over 12 major national and institutional research grants, reflecting his leadership in Korea’s brain rehabilitation landscape πŸŽ–οΈ. His grant-funded projects include innovations in rTMS, tDCS, and rehabilitation robotics, supported by prestigious bodies like the National Research Foundation of Korea, Ministry of Health and Welfare, and Samsung Medical Center πŸ§ͺ. Notable among these is the First-Ever Stroke Long-Term Cohort Study (2023–2032), a landmark effort funded by the Korea Disease Control and Prevention Agency. He is widely recognized for his work in personalized neurorehabilitation, stroke biomarkers, and digital recovery platforms. His editorial and board roles in global journals and societies further mark him as a respected thought leader in rehabilitation medicine, contributing to the scientific community through both service and research excellence πŸ₯‡πŸ“œ.

πŸ”¬ Research Focus

Prof. Chang’s research is centered on neurorehabilitation for stroke and brain disorders, with specialization in non-invasive brain stimulation techniques like repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) 🧠⚑. He leads pioneering work on developing smart rehabilitation tools, such as smart gloves and boards for upper limb recovery, and Angel Legs, a robotic walking device. His studies aim to create personalized treatment strategies based on genetic and neurological markers, like BDNF polymorphisms, to optimize therapy outcomes. Additionally, he investigates brain plasticity, motor learning, and the digital transformation of rehabilitation practices. His interdisciplinary approach integrates AI, sensor technology, and cohort studies to improve long-term outcomes for stroke survivors. Dr. Chang’s innovations are backed by extensive funding and have significant implications for global brain health, aging care, and telerehabilitation πŸ“ˆπŸ€–πŸ§¬.

Publication Top Notes

πŸ“… 2025 | Risk of Atrial Fibrillation After Hemorrhagic Stroke | Circulation | πŸ” DOI: 10.1161/CIRCULATIONAHA.124.070662 | πŸ“‘
πŸ“… 2025 | Increased Risk of End-Stage Kidney Disease After Traumatic Amputation | Healthcare | πŸ” DOI: 10.3390/healthcare13010080 | πŸ“‘
πŸ“… 2024 | Factors Associated With Post-Stroke Cognitive Impairment | Brain & Neurorehabilitation | πŸ” DOI: 10.12786/bn.2024.17.e20 | πŸ“š
πŸ“… 2024 | Initial Controlling Nutritional Status Score & Stroke Outcomes | Nutrients | πŸ” DOI: 10.3390/nu16203461 | πŸ“Š
πŸ“… 2024 | Quantitative Disability Tool in Parkinson’s Disease | Diagnostics | πŸ” DOI: 10.3390/diagnostics14182063 | πŸ€–
πŸ“… 2024 | Risk of Diabetes After Spinal Cord Injury | Healthcare | πŸ” DOI: 10.3390/healthcare12181859 | 🧠
πŸ“… 2024 | Height & Functional Outcomes After Stroke | J. of Personalized Medicine | πŸ” DOI: 10.3390/jpm14060610 | πŸ“
πŸ“… 2024 | Fracture Risk Post-Stroke by Disability Status | Stroke | πŸ” DOI: 10.1161/STROKEAHA.123.044953 | 🦴
πŸ“… 2024 | No Additional Effects of Sequential rTMS in Stroke | J. of Personalized Medicine | πŸ” DOI: 10.3390/jpm14070687 | 🧲
πŸ“… 2024 | Heart Disease Risk in Amputation Patients | JAHA | πŸ” DOI: 10.1161/JAHA.123.033304 | ❀️
πŸ“… 2024 | Parkinson Disease Risk After Stroke | European Journal of Neurology | πŸ” DOI: 10.1111/ene.16194 | 🧠
πŸ“… 2024 | Caregiver Burden After First-Ever Stroke | Medicina | πŸ” DOI: 10.3390/medicina60040559 | 🀝
πŸ“… 2024 | Abnormal Synergies in Stroke Phases | Preprint | πŸ” DOI: 10.1101/2024.02.07.24302477 | πŸ”„
πŸ“… 2023 | Fracture Risk Post-Stroke by Disability (Preprint) | Preprint | πŸ” DOI: 10.1101/2023.12.19.23300259 | 🧩
πŸ“… 2023 | Pretransplant Functional Status in Liver Transplantation | Gut and Liver | πŸ” DOI: 10.5009/gnl220337 | πŸ₯
πŸ“… 2023 | Wearable Robot in Stroke Rehab – Protocol Study | BMJ Open | πŸ” DOI: 10.1136/bmjopen-2022-065298 | πŸ€–

Francesco Latini | White matter | Best Researcher Award

Assoc. Prof. Dr. Francesco Latini | White matter | Best Researcher Award

Assoc. Prof. Dr. Francesco Latini, Uppsala University Hospital, Sweden

Assoc. Prof. Dr. Francesco Latini, M.D., Ph.D., is an Associate Professor in Neurosurgery at Uppsala University Hospital, Sweden. His expertise spans general neurosurgery, neuro-oncology, and cerebrovascular diseases. With a deep interest in brain connectivity and gliomas, Dr. Latini has contributed significantly to advancing neurosurgical practices. He leads the Neurointermediate Intensive Care Unit and coordinates regional clinical processes for malignant brain tumors. πŸŒπŸ§ πŸ’‰

Publication Profile

Google Scholar

Education

Dr. Latini graduated in 2006 from the University of Bologna, Italy. He completed his specialization in Neurosurgery in 2013 (cum laude) at the University of Ferrara, Italy. In 2021, he earned a Ph.D. in Medical Sciences from Uppsala University, focusing on the anatomy and behavior of low-grade gliomas. His training includes specialized fellowships in neurovascular surgery and neuro-oncology at various prestigious institutions worldwide. πŸŽ“πŸ“šπŸ₯

Experience

Dr. Latini’s career spans from Resident in Neurosurgery at S.Anna University-Hospital, Ferrara (2008-2013) to roles in Uppsala University-Hospital since 2014. He has held positions as a ward physician, junior consultant, and senior consultant in neurosurgery. Currently, he heads the Neurointermediate Intensive Care Unit and serves as the regional coordinator for malignant brain tumor clinical processes. He is also an associate professor in neurosurgery. πŸ₯πŸ§‘β€βš•οΈπŸ’Ό

Awards and Honors

Dr. Latini has received numerous awards for his contributions to neurosurgery, including recognition for his work in neuro-oncology and cerebrovascular diseases. He is highly regarded in both research and clinical practice and has been acknowledged for his clinical leadership in brain tumor management and neurosurgical innovation. His honors reflect his excellence in both teaching and surgical practice. πŸ†πŸŽ–οΈπŸŒŸ

Research Focus

Dr. Latini’s research primarily focuses on the role of white matter anatomy in the behavior and surgical treatment of low-grade gliomas. He explores the radiological and histopathological features of diffuse gliomas, aiming to develop new models for their treatment. His work bridges the gap between clinical neurosurgery and advanced imaging technologies, emphasizing preoperative planning and patient outcomes. πŸ§ πŸ”¬

Publication Top Notes
  • Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III – Cited by: 118 – Year: 2014 πŸ§ πŸ“‘

  • Segmentation of the inferior longitudinal fasciculus in the human brain: A white matter dissection and diffusion tensor tractography study – Cited by: 117 – Year: 2017 πŸ§ πŸ“Š

  • Extension of diffuse low-grade gliomas beyond radiological borders as shown by the coregistration of histopathological and magnetic resonance imaging data – Cited by: 80 – Year: 2016 🧠🩻

  • The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power – Cited by: 58 – Year: 2018 πŸ§ βš–οΈ

  • New insights in the limbic modulation of visual inputs: The role of the inferior longitudinal fasciculus and the Li-Am bundle – Cited by: 55 – Year: 2014 πŸ§ πŸ”¬

  • Awake surgery in low-grade gliomas harboring eloquent areas: 3-year mean follow-up – Cited by: 49 – Year: 2011 πŸ§ πŸ’‰

  • Time course of neurological deficits after surgery for primary brain tumours – Cited by: 47 – Year: 2020 πŸ§ πŸ•°οΈ

  • Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry – Cited by: 46 – Year: 2014 πŸ§ πŸ“ˆ

  • Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson’s disease – Cited by: 46 – Year: 2010 πŸ§ βš–οΈ

  • Is the resection of gliomas in Wernicke’s area reliable? – Cited by: 45 – Year: 2012 πŸ§ πŸ’¬

  • miRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time PCR – Cited by: 39 – Year: 2012 πŸ§ πŸ”¬

  • The use of a cerebral perfusion and immersion–fixation process for subsequent white matter dissection – Cited by: 34 – Year: 2015 πŸ§ βš™οΈ

  • Mobilization of the transcavernous oculomotor nerve during basilar aneurysm surgery: biomechanical bases for better outcome – Cited by: 34 – Year: 2014 πŸ§ βš™οΈ

  • New insights into the anatomy, connectivity and clinical implications of the middle longitudinal fasciculus – Cited by: 33 – Year: 2021 🧠🌐

  • Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference – Cited by: 32 – Year: 2013 πŸ§ πŸ“š

Beatriz Veiga | Neuroscience | Best Researcher Award

Dr. Beatriz Veiga | Neuroscience | Best Researcher Award

Dr. Beatriz Veiga, Universidade Federal de SΓ£o Paulo, Brazil

Dr. Beatriz Azevedo dos Anjos Godke Veiga is a Brazilian neurologist with a focus on movement disorders. She completed her medical degree in 2001 at Universidade Estadual de Londrina, followed by a Master’s and Doctorate in Neurology/Neurosciences at Universidade Federal de SΓ£o Paulo (UNIFESP). Her doctoral research, completed in 2023, examined the association between compulsive behaviors and levodopa-induced dyskinesias in Parkinson’s disease patients. Dr. Veiga is currently a neurologist at Hospital Ipiranga and a faculty member at Universidade Nove de Julho. Her research interests include impulsive behaviors, dyskinesias, and Parkinson’s disease. She has received multiple awards, including the International Congress Travel Grant Award from the Movement Disorders Society in 2019 and 2022. Her published work includes articles on depression in Parkinson’s disease and fatigue in geriatric patients. Dr. Veiga is actively involved in several research projects, particularly those exploring the relationship between early-onset Parkinson’s disease and dopamine agonists.

Publication Profile

Orcid

Awards and Titles πŸ†

Dr. Beatriz Veiga has earned significant recognition in the field of movement disorders. In 2022, she was awarded the International Congress Travel Grant Award by the Movement Disorders Society 🌍, highlighting her contributions and research in this specialized area. This prestigious honor was preceded by another International Congress Travel Grant Award in 2019, further solidifying her standing within the international scientific community. Dr. Veiga’s continuous dedication to advancing the understanding of movement disorders has positioned her as a prominent figure in the field, earning accolades for her expertise and commitment to research. 🌟

 

Academic Background πŸŽ“

Dr. Beatriz Veiga’s academic journey has been marked by excellence in the field of Neurology and Neurosciences. She completed her PhD in Neurology/Neurosciences at the Federal University of SΓ£o Paulo (UNIFESP), Brazil, in 2023, with a thesis on the association between compulsive impulsive behaviors and levodopa-induced dyskinesias in Parkinson’s disease patients 🧠. Dr. Veiga also holds a Master’s degree from UNIFESP (2008), focusing on depression in Parkinson’s disease. Her medical residency in Neurology was completed at the State University of Londrina (UEL), Brazil, where she was a CNPq scholar. She holds a degree in Medicine from UEL (2001). πŸŽ“

 

Complementary Education πŸ“š

Dr. Beatriz Veiga has enhanced her expertise in Neurology through specialized training. In 2019, she completed a short course in Deep Brain Stimulation (DBS) at the International Academy, gaining 25 hours of focused learning on this advanced therapy for movement disorders 🧠. She also participated in an Observership program at the Movement Disorders Clinic, University of Toronto, with a focus on DBS, accumulating 160 hours of hands-on experience. Dr. Veiga is a Neurologist and Preceptor at Hospital Ipiranga, and a faculty member at the University of Nove de Julho, specializing in movement disorders. πŸ’‘

 

Professional Experience πŸ₯

Dr. Beatriz Veiga has extensive professional experience in Neurology and academia. Since 2008, she has been a Full Member of the Academia Brasileira de Neurologia (ABN). She is also an active member of the Movement Disorder Society (MDS) since 2017. Dr. Veiga is a Faculty Member at the University of Nove de Julho (UNINOVE) since 2012, where she teaches in the Medicine program 🩺. Additionally, she has served as a Neurologist and Preceptor at Hospital Ipiranga since 2010, training the next generation of neurologists. Her expertise has been pivotal in the field of movement disorders. 🌟

 

Research Focus

Dr. Beatriz A. Anjos G. Veiga’s research primarily focuses on neurology and movement disorders, specifically the relationship between impulsive-compulsive behaviors (ICBs) and Levodopa-induced dyskinesia (LID) in Parkinson’s disease. Her work, demonstrated in the study “Are Impulsive Compulsive Behaviors Associated with Levodopa-Induced Dyskinesia?”, explores how these behaviors contribute to the clinical presentation of Parkinson’s disease and its treatment. She investigates the neurophysiological mechanisms behind these effects, aiming to improve therapeutic strategies. Her research contributes significantly to understanding the cognitive and motor complications of Parkinson’s disease and optimizing management strategies. πŸ©ΊπŸ”¬

 

Publication Top Notes

Are Impulsive Compulsive Behaviors Associated with Levodopa-Induced Dyskinesia? A Brazilian Cross-Sectional Study